Skip to main content
. Author manuscript; available in PMC: 2016 Apr 4.
Published in final edited form as: J Endocrinol Diabetes Obes. 2014 Dec 31;3(1):1065.

Figure 4.

Figure 4

(A) Change in fasting blood glucose, ITT population. D-tagatose significantly decreased fasting blood glucose compared to placebo after 6 months of treatment. (B) Change in fasting blood glucose levels, PP population. No significant difference between placebo and D-tagatose groups was observed at any time point. Zero time points plotted as means, remaining time points plotted as least squares means ±SEM.